-
1
-
-
14944385553
-
Global cancer statistics, 2002
-
Parkin D, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
-
(2005)
CA Cancer J Clin
, vol.55
, pp. 74-108
-
-
Parkin, D.1
Bray, F.2
Ferlay, J.3
-
2
-
-
0036483583
-
Current surgical treatment of non-small cell lung cancer 2001
-
Deslauriers J. Current surgical treatment of non-small cell lung cancer 2001. Eur Respir J Suppl. 2002;35:61s-70s.
-
(2002)
Eur Respir J Suppl
, vol.35
-
-
Deslauriers, J.1
-
3
-
-
0346238665
-
Cisplatin-based adjuvant chemotherapy in patients with completely resected nonsmall cell lung cancer
-
Amagada R, Bergman B, Dunant A et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected nonsmall cell lung cancer. N Engl J Med. 2004;350:351-360.
-
(2004)
N Engl J Med
, vol.350
, pp. 351-360
-
-
Amagada, R.1
Bergman, B.2
Dunant, A.3
-
4
-
-
20544455590
-
Vinorelbine plus cisplatin vs. observation in resected non-small cell lung cancer
-
Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small cell lung cancer. N Engl J Med. 2005;352:2589-2597.
-
(2005)
N Engl J Med
, vol.352
, pp. 2589-2597
-
-
Winton, T.1
Livingston, R.2
Johnson, D.3
-
5
-
-
22444432345
-
ANITA: Phase III adjuvant vinorelbine and cisplatin versus observation in completely resected. (Stagel-III) non-small cell lung cancer patients: final results after 70-month median follow-up [abstract 7013]
-
Douillard. J, Roseli R, Delena M, et al. ANITA: phase III adjuvant vinorelbine and cisplatin versus observation in completely resected. (Stagel-III) non-small cell lung cancer patients: final results after 70-month median follow-up [abstract 7013]. J Clin Oncol. 2005;23:624S.
-
(2005)
J Clin Oncol
, vol.23
-
-
Douillard, J.1
Roseli, R.2
Delena, M.3
-
6
-
-
33747829509
-
Adjuvant chemotherapy in Stage IB non-small cell lung cancer: Update of CALGB protocol. 9633 [abstract 7007]
-
Strauss GM, Herdon JE, Maddaus MA, et al. Adjuvant chemotherapy in Stage IB non-small cell lung cancer: update of CALGB protocol. 9633 [abstract 7007]. J Clin Oncol. 2006;24:365S.
-
(2006)
J Clin Oncol
, vol.24
-
-
Strauss, G.M.1
Herdon, J.E.2
Maddaus, M.A.3
-
7
-
-
50949083304
-
Adjuvant treatment of Stage IB NSCLC
-
Calhoun R, Jablons D, Lau D, et al. Adjuvant treatment of Stage IB NSCLC. Oncology. 2008;22:511-516.
-
(2008)
Oncology
, vol.22
, pp. 511-516
-
-
Calhoun, R.1
Jablons, D.2
Lau, D.3
-
8
-
-
55449138473
-
Long-term results of the International Adjuvant Lung Cancer Trial (IALT) evaluating adjuvant cisplatin-based chemotherapy in resected non-small cell lung cancer (NSCLC) [abstract 7507]
-
LeChevalier T, Dunant A, Amagada R, et al. Long-term results of the International Adjuvant Lung Cancer Trial (IALT) evaluating adjuvant cisplatin-based chemotherapy in resected non-small cell lung cancer (NSCLC) [abstract 7507]. J Clin Oncol. 2008;26:398S.
-
(2008)
J Clin Oncol
, vol.26
-
-
LeChevalier, T.1
Dunant, A.2
Amagada, R.3
-
9
-
-
0029089012
-
Randomized trial of lobectomy versus limited resection for TINO non-small cell lung cancer. Lung Cancer Study Group
-
Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for TINO non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60:615-623.
-
(1995)
Ann Thorac Surg
, vol.60
, pp. 615-623
-
-
Ginsberg, R.J.1
Rubinstein, L.V.2
-
10
-
-
33745192066
-
Patterns of failure after resection of non-small-cell lung cancer: Implications for postoperative radiation therapy volumes
-
Kelsey CR, Light KL, Marks LB. Patterns of failure after resection of non-small-cell lung cancer: implications for postoperative radiation therapy volumes. Int J Radiat Oncol Biol Phys. 2006;65:1097-1105.
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.65
, pp. 1097-1105
-
-
Kelsey, C.R.1
Light, K.L.2
Marks, L.B.3
-
11
-
-
33845382806
-
Non-parametric estimation from incomplete observation
-
Kaplan ES, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc. 1958;53:475-480.
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 475-480
-
-
Kaplan, E.S.1
Meier, P.2
-
12
-
-
0000336139
-
Regression models and life tables
-
Cox DR. Regression models and life tables. JR Stat Soc B. 1972;34:187-220.
-
(1972)
JR Stat Soc B
, vol.34
, pp. 187-220
-
-
Cox, D.R.1
-
13
-
-
0020803058
-
Prognostic significance of parenchymal lymphatic vessel and blood vessel invasion in carcinoma of the lung
-
Shields TW. Prognostic significance of parenchymal lymphatic vessel and blood vessel invasion in carcinoma of the lung. Surg Gyn Obstet. 1983;157:185-190.
-
(1983)
Surg Gyn Obstet
, vol.157
, pp. 185-190
-
-
Shields, T.W.1
-
14
-
-
0029910834
-
Blood vessel and lymphatic vessel invasion in resected non-small cell lung carcinoma: Correlation with TNM stage and disease free and overall survival
-
Brechot JM, Chevret S, Charpentier MC, et al. Blood vessel and lymphatic vessel invasion in resected non-small cell lung carcinoma: correlation with TNM stage and disease free and overall survival. Cancer. 1996;78:2111-2118.
-
(1996)
Cancer
, vol.78
, pp. 2111-2118
-
-
Brechot, J.M.1
Chevret, S.2
Charpentier, M.C.3
-
15
-
-
0033491571
-
Prognostic Factors in T1N0M0 adenocarcinomas and bronchioloalveolar carcinomas of the lung
-
Goldstein NS, Mani A, Chmielewski G, et al. Prognostic Factors in T1N0M0 adenocarcinomas and bronchioloalveolar carcinomas of the lung. Am J Clin Pathol. 1999;112:391-402.
-
(1999)
Am J Clin Pathol
, vol.112
, pp. 391-402
-
-
Goldstein, N.S.1
Mani, A.2
Chmielewski, G.3
-
16
-
-
18744431008
-
Biological prognostic factors for early stage completely resected non-small lung cancer
-
Cagini L, Monacelli M, Giustozzi G, et al. Biological prognostic factors for early stage completely resected non-small lung cancer. J Surg Oncol, 2000;74:53-60.
-
(2000)
J Surg Oncol
, vol.74
, pp. 53-60
-
-
Cagini, L.1
Monacelli, M.2
Giustozzi, G.3
-
17
-
-
20244388951
-
Molecular pathologic substaging in 244 Stage I non-small cell lung cancer patients: Clinical implications
-
Kwiatkowski DJ, Harpole DH, Godleski J, et al. Molecular pathologic substaging in 244 Stage I non-small cell lung cancer patients: clinical implications. J Clin Oncol. 1998; 16:2468-2477.
-
(1998)
J Clin Oncol
, vol.16
, pp. 2468-2477
-
-
Kwiatkowski, D.J.1
Harpole, D.H.2
Godleski, J.3
-
18
-
-
0036714218
-
Overweight, obesity, and cancer risk
-
Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol. 2002;3:565-574.
-
(2002)
Lancet Oncol
, vol.3
, pp. 565-574
-
-
Bianchini, F.1
Kaaks, R.2
Vainio, H.3
-
19
-
-
0037464510
-
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults
-
Callee EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625-1638.
-
(2003)
N Engl J Med
, vol.348
, pp. 1625-1638
-
-
Callee, E.E.1
Rodriguez, C.2
Walker-Thurmond, K.3
-
20
-
-
36049048877
-
Prediagnosis smoking, obesity, insulin resistance, and second primary cancer risk in male cancer survivors: National Health Insurance Corporation Study
-
Park SM, Lim MK, Jung KW, et al. Prediagnosis smoking, obesity, insulin resistance, and second primary cancer risk in male cancer survivors: National Health Insurance Corporation Study. J Clin Oncol. 2007;25:4835-4843.
-
(2007)
J Clin Oncol
, vol.25
, pp. 4835-4843
-
-
Park, S.M.1
Lim, M.K.2
Jung, K.W.3
-
21
-
-
0346217043
-
Long-term risk of malignant neoplasm associated with gestational glucose intolerance
-
Dawson SI. Long-term risk of malignant neoplasm associated with gestational glucose intolerance. Cancer. 2004;100: 149-155.
-
(2004)
Cancer
, vol.100
, pp. 149-155
-
-
Dawson, S.I.1
-
22
-
-
0037248713
-
Insulin resistance and prostate cancer risk
-
Hsing AW, Gao YT, Chua S, et al. Insulin resistance and prostate cancer risk. J Natl Cancer Inst. 2003;95:67-71.
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 67-71
-
-
Hsing, A.W.1
Gao, Y.T.2
Chua, S.3
-
23
-
-
11844259994
-
Fasting serum glucose level and cancer risk in Korean men and women
-
Jee SH, Ohrr H, Sull JW, et al. Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 2005;293:194-202.
-
(2005)
JAMA
, vol.293
, pp. 194-202
-
-
Jee, S.H.1
Ohrr, H.2
Sull, J.W.3
-
24
-
-
0034679058
-
Abnormal glucose metabolism and pancreatic cancer mortality
-
Gapstur SM, Gann PH, Lowe W, et al. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA. 2000; 283:2552-2558.
-
(2000)
JAMA
, vol.283
, pp. 2552-2558
-
-
Gapstur, S.M.1
Gann, P.H.2
Lowe, W.3
-
25
-
-
34248192254
-
Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes
-
Govindarajan R, Ratnasinghe L, Simmons DL, et al. Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes. J Clin Oncol, 2007; 25:1476-1481.
-
(2007)
J Clin Oncol
, vol.25
, pp. 1476-1481
-
-
Govindarajan, R.1
Ratnasinghe, L.2
Simmons, D.L.3
-
26
-
-
34347353320
-
Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase
-
Hazra S, Batra RK, Tai HH, et al. Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase. Mol Pharmacol. 2007;71:1715-1720.
-
(2007)
Mol Pharmacol
, vol.71
, pp. 1715-1720
-
-
Hazra, S.1
Batra, R.K.2
Tai, H.H.3
-
27
-
-
77954787033
-
Differential impact of anti-diabetic treatments on pancreatic cancer cell growth in cell culture conditions mimicking different stages in the natural history of diabetes mellitus type 2 [abstract 4640]
-
Feng Y, Busaidy N, Lee M, et al. Differential impact of anti-diabetic treatments on pancreatic cancer cell growth in cell culture conditions mimicking different stages in the natural history of diabetes mellitus type 2 [abstract 4640]. J Clin Oncol. 2008;26:248S.
-
(2008)
J Clin Oncol
, vol.26
-
-
Feng, Y.1
Busaidy, N.2
Lee, M.3
-
28
-
-
61449207441
-
The effects of metformin on pathologic complete response (pCR) rates in diabetic breast cancer(BC) patients receiving neoadjuvant systemic therapy [abstract 528]
-
Jiralerspong S, Giordano SH, Meric-Bernstam F, et al. The effects of metformin on pathologic complete response (pCR) rates in diabetic breast cancer(BC) patients receiving neoadjuvant systemic therapy [abstract 528]. J Clin Oncol. 2008;26:13S.
-
(2008)
J Clin Oncol
, vol.26
-
-
Jiralerspong, S.1
Giordano, S.H.2
Meric-Bernstam, F.3
-
29
-
-
0021203376
-
Postsurgical stage I bronchogenic carcinoma: Morbid implications of recurrent disease
-
Pairolero PC, Williams DE, Bergstralh EJ, et al. Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thorac Surg. 1984;38:331-338.
-
(1984)
Ann Thorac Surg
, vol.38
, pp. 331-338
-
-
Pairolero, P.C.1
Williams, D.E.2
Bergstralh, E.J.3
-
30
-
-
33749045220
-
4-year mortality in patients with non-small-cell lung cancer: Development and validation of a prognostic index
-
Blanchon F, Grivaux M, Asselain B, et al. 4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index. Lancet Oncol. 2006; 7:829-836.
-
(2006)
Lancet Oncol
, vol.7
, pp. 829-836
-
-
Blanchon, F.1
Grivaux, M.2
Asselain, B.3
-
31
-
-
0029046361
-
New prognostic factors in lung cancer. Biologic prophets of cancer cell aggression
-
Mountain CF. New prognostic factors in lung cancer. Biologic prophets of cancer cell aggression. Chest. 1995; 108: 246-254.
-
(1995)
Chest
, vol.108
, pp. 246-254
-
-
Mountain, C.F.1
-
32
-
-
0033994195
-
-
van Rens MT, de la Riviere AB, Eibers HR, et al. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest. 2000;117:374-379.
-
van Rens MT, de la Riviere AB, Eibers HR, et al. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest. 2000;117:374-379.
-
-
-
-
33
-
-
1842585074
-
Sleeve lobectomy versus pneumonectomy for lung cancer: A comparative analysis of survival and sites or recurrences
-
Deslauriers J, Gregoire J, Jacques LF, et al. Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences. Ann Thorac Surg. 2004;77:1152-1156.
-
(2004)
Ann Thorac Surg
, vol.77
, pp. 1152-1156
-
-
Deslauriers, J.1
Gregoire, J.2
Jacques, L.F.3
-
34
-
-
41149085641
-
A comparison of survival and disease-specific survival in surgically resected, lymph node-positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer: Implications for adjuvant therapy
-
Varlotto JM, Flickinger JC, Recht A, et al. A comparison of survival and disease-specific survival in surgically resected, lymph node-positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer: implications for adjuvant therapy. Cancer. 2008;112:1547-1554.
-
(2008)
Cancer
, vol.112
, pp. 1547-1554
-
-
Varlotto, J.M.1
Flickinger, J.C.2
Recht, A.3
-
35
-
-
61449139405
-
Factors associated with local, distant, overall recurrence in surgically-resected non-small cell lung cancer and the role of diabetes in local recurrence [abstract 7572]
-
Varlotto JM, Flickinger JC, Medford-Davis LN, et al. Factors associated with local, distant, overall recurrence in surgically-resected non-small cell lung cancer and the role of diabetes in local recurrence [abstract 7572]. J Clin Oncol. 2008;26:415S.
-
(2008)
J Clin Oncol
, vol.26
-
-
Varlotto, J.M.1
Flickinger, J.C.2
Medford-Davis, L.N.3
-
36
-
-
0026481389
-
Locally recurrent non-small-cell lung cancer after complete surgical resection
-
Shaw EG, Brindle JS, Creagan ET, et al. Locally recurrent non-small-cell lung cancer after complete surgical resection. Mayo Clin Proc. 1992;67:1197-1200.
-
(1992)
Mayo Clin Proc
, vol.67
, pp. 1197-1200
-
-
Shaw, E.G.1
Brindle, J.S.2
Creagan, E.T.3
-
37
-
-
0028157741
-
Local recurrence after complete resection for non-small-cell carcinoma of the lung. Significance of local control by radiation treatment
-
Yano T, Hara N, Ichinose Y, et al. Local recurrence after complete resection for non-small-cell carcinoma of the lung. Significance of local control by radiation treatment. J Thorac Cardiovasc Surg. 1994;107:8-112.
-
(1994)
J Thorac Cardiovasc Surg
, vol.107
, pp. 8-112
-
-
Yano, T.1
Hara, N.2
Ichinose, Y.3
-
38
-
-
0033782875
-
Relevance of an intensive postoperative follow-up after surgery for nonsmall cell lung cancer
-
Westeel V, Choma D, Clement F. Relevance of an intensive postoperative follow-up after surgery for nonsmall cell lung cancer. Ann Thorac Surg. 2000;70:1185-1190.
-
(2000)
Ann Thorac Surg
, vol.70
, pp. 1185-1190
-
-
Westeel, V.1
Choma, D.2
Clement, F.3
-
39
-
-
61449210108
-
-
Ettinger DS, Ackerley W, Bepler G, et al. National Comprehensive Cancer Network. Practice guidelines in oncology - v. 2.2008. Fort Washington, PA: NCCN.
-
Ettinger DS, Ackerley W, Bepler G, et al. National Comprehensive Cancer Network. Practice guidelines in oncology - v. 2.2008. Fort Washington, PA: NCCN.
-
-
-
|